U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9948199481Tai Chi Training for Treating Depressed Chinese AmericansCompletedNo Results AvailableMajor Depressive DisorderBehavioral: Tai Chihttps://ClinicalTrials.gov/show/NCT01263730
9948299482Effects of Growth Hormone Releasing Hormone in HIVCompletedHas ResultsHIV|HIV LipodystrophyDrug: tesamorelin|Drug: placebohttps://ClinicalTrials.gov/show/NCT01263717
9948399483A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic LeukemiaActive, not recruitingNo Results AvailableLymphocytic Leukemia, ChronicDrug: cyclophosphamide|Drug: fludarabine|Drug: rituximab [MabThera/Rituxan]https://ClinicalTrials.gov/show/NCT01263704
9948499484Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy AdultsCompletedHas ResultsBacillus Anthracis (Anthrax) InfectionBiological: BioThrax|Biological: AV7909 Formulation 1|Biological: AV7909 Formulation 2|Biological: AV7909 Formulation 3|Biological: AV7909 Formulation 4|Drug: Controlhttps://ClinicalTrials.gov/show/NCT01263691
9948599485Helping Patients With Spinal Stenosis Make a Treatment Decision: A Randomized Study Assessing The Benefits of Health CoachingCompletedNo Results AvailableSpinal StenosisBehavioral: Coaching|Other: Usual Carehttps://ClinicalTrials.gov/show/NCT01263678
9948699486Evaluation of the 25 Centimeter (cm) GORE® VIABAHN® EndoprosthesisActive, not recruitingHas ResultsPeripheral Vascular DiseasesDevice: 25 cm GORE® VIABAHN®https://ClinicalTrials.gov/show/NCT01263665
9948799487Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine PatientsNot yet recruitingNo Results AvailablePain ReliefDrug: Diclofenac hydroxyethylpyrrolidine|Drug: orphenadrine|Drug: Tramadol|Drug: Dipyronehttps://ClinicalTrials.gov/show/NCT01263652
9948899488Improving Patient Satisfaction Improving Patient SatisfactionCompletedHas ResultsSatisfaction|TraumaOther: Orthopaedic Attending Biosketch Card|Other: Standard of care - No biosketch cardhttps://ClinicalTrials.gov/show/NCT01263639
9948999489Cough Monitoring StudyCompletedNo Results AvailableCough|Refluxhttps://ClinicalTrials.gov/show/NCT01263626
9949099490Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast CancerCompletedNo Results AvailableBreast CancerProcedure: tumor biopsy and blood drawhttps://ClinicalTrials.gov/show/NCT01263613
9949199491Hepatitis B Research Network Pediatric Cohort Study (HBRN)RecruitingNo Results AvailableHepatitis Bhttps://ClinicalTrials.gov/show/NCT01263600
9949299492Hepatitis B Research Network Adult Cohort StudyRecruitingNo Results AvailableHepatitis Bhttps://ClinicalTrials.gov/show/NCT01263587
9949399493Trial of 70% Ethanol Versus Heparin to Reduce the Rate of Central Line Infections in Children With Short Bowel SyndromeNot yet recruitingNo Results AvailableCatheter Related Infections|Short Bowel SyndromeDrug: 70% ethanolhttps://ClinicalTrials.gov/show/NCT01263574
9949499494Prospective Randomized Study Comparing Ex-PRESS to TrabeculectomyCompletedHas ResultsGlaucomaProcedure: ExPRESS shunt|Procedure: trabeculectomyhttps://ClinicalTrials.gov/show/NCT01263561
9949599495To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II DisorderCompletedNo Results AvailableAttention Deficit/Hyperactivity Disorder|Bipolar DisorderDrug: lisdexamfetamine dimesylatehttps://ClinicalTrials.gov/show/NCT01263548
9949699496Use of an Ocular Telemetry Sensor in Tafluprost Treated PatientsTerminatedNo Results AvailableGlaucomaDevice: SENSIMED Triggerfishhttps://ClinicalTrials.gov/show/NCT01263535
9949799497Optimization of Preventive Effects of Physical TrainingRecruitingNo Results AvailablePrimary Prevention, Cardiovascular Risk Factor Management, Size of Response to TrainingOther: different training programs|Other: control conditionhttps://ClinicalTrials.gov/show/NCT01263522
9949899498Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in JapanCompletedHas ResultsType 2 Diabetes MellitusDrug: Alogliptin and voglibose|Drug: Alogliptin and voglibosehttps://ClinicalTrials.gov/show/NCT01263509
9949999499Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in JapanCompletedHas ResultsType 2 Diabetes MellitusDrug: Alogliptin|Drug: Alogliptin|Drug: Alogliptin|Drug: Alogliptin|Drug: Voglibosehttps://ClinicalTrials.gov/show/NCT01263496
9950099500Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in JapanCompletedHas ResultsType 2 Diabetes MellitusDrug: Alogliptin and voglibose|Drug: Alogliptin and voglibose|Drug: Voglibosehttps://ClinicalTrials.gov/show/NCT01263483
9950199501Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in JapanCompletedHas ResultsDiabetes Mellitus, Type 2Drug: Alogliptin|Drug: Alogliptin|Drug: Alogliptin|Drug: Alogliptin|Drug: Voglibose|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01263470
9950299502To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UKActive, not recruitingNo Results AvailableGrowth DisordersDevice: Easypodhttps://ClinicalTrials.gov/show/NCT01263457
9950399503Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin TherapyCompletedHas ResultsGlaucoma|Ocular HypertensionDrug: Brinzolamide 1% / timolol 0.5% Fixed Combination|Drug: Habitual prostaglandin monotherapyhttps://ClinicalTrials.gov/show/NCT01263444
9950499504Comparison Between Excisional Hemorrhoidectomy and Haemorrhoidal Dearterialisation With AnopexyCompletedNo Results AvailableThird Degree HemorrhoidsProcedure: Hemorrhoidectomy|Procedure: Hemorrhoidal dearterializationhttps://ClinicalTrials.gov/show/NCT01263431
9950599505Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell LymphomasWithdrawnNo Results AvailableLymphoma, Non-Hodgkin|Lymphoma, Follicular|Lymphoma, B-Cell, Marginal Zone|Lymphoma, Low-Grade|Lymphoma, Intermediate-GradeDrug: Ofatumumabhttps://ClinicalTrials.gov/show/NCT01263418
9950699506Monitoring Chemotherapy Response of Soft Tissue Sarcomas and Osteosarcomas Using Diffuse Optical Spectroscopic ImagingCompletedNo Results AvailableSarcomahttps://ClinicalTrials.gov/show/NCT01263405
9950799507Comparing Urinary Tract Infections in Children With Spina Bifida Using Two Types of Catheters for CatheterizationCompletedNo Results AvailableNeurogenic Bladder|Spina BifidaDevice: Intermittent catheterizationhttps://ClinicalTrials.gov/show/NCT01263392
9950899508Gene Transfer for Recessive Dystrophic Epidermolysis BullosaRecruitingNo Results AvailableEpidermolysis Bullosa Dystrophica|Epidermolysis BullosaGenetic: LZRSE-Col7A1 Engineered Autologous Epidermal Sheets (LEAES)https://ClinicalTrials.gov/show/NCT01263379
9950999509Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer PatientsTerminatedNo Results AvailableRadiodermatitisDrug: Norepinephrinehttps://ClinicalTrials.gov/show/NCT01263366
9951099510Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETsCompletedNo Results AvailableGastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic SystemDrug: Pasireotide LAR followed by Pasireotide LAR + Everolimus|Drug: Everolimus followed by Pasireotide LAR + Everolimushttps://ClinicalTrials.gov/show/NCT01263353

* Görseller ve İçerik tekif hakkına sahip olabilir